Allspring Global Investments Holdings LLC Decreases Stock Position in Integer Holdings Co. (NYSE:ITGR)

Allspring Global Investments Holdings LLC lessened its stake in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 9.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 194,678 shares of the medical equipment provider's stock after selling 20,077 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.58% of Integer worth $25,308,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Contravisory Investment Management Inc. raised its holdings in Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 80 shares during the period. Xponance Inc. grew its position in Integer by 4.9% in the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider's stock valued at $245,000 after acquiring an additional 99 shares during the last quarter. Azzad Asset Management Inc. ADV grew its position in Integer by 0.9% in the 3rd quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider's stock valued at $1,504,000 after acquiring an additional 107 shares during the last quarter. GAMMA Investing LLC grew its position in Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock valued at $43,000 after acquiring an additional 142 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its position in Integer by 3.6% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider's stock valued at $689,000 after acquiring an additional 205 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Stock Up 0.2 %

Shares of ITGR traded up $0.31 during midday trading on Thursday, reaching $126.84. 524,924 shares of the stock were exchanged, compared to its average volume of 312,988. Integer Holdings Co. has a 52 week low of $69.40 and a 52 week high of $133.53. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. The company's 50 day moving average is $127.37 and its two-hundred day moving average is $120.86. The company has a market capitalization of $4.25 billion, a P/E ratio of 43.86, a PEG ratio of 1.86 and a beta of 1.08.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.07. The firm had revenue of $431.42 million during the quarter, compared to analysts' expectations of $440.59 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. The firm's quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.27 EPS. On average, sell-side analysts anticipate that Integer Holdings Co. will post 5.3 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Jean M. Hobby sold 11,960 shares of the company's stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the sale, the director now directly owns 2,280 shares in the company, valued at $272,824.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 2.00% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. Citigroup upped their price objective on Integer from $124.00 to $130.00 and gave the company a "neutral" rating in a research report on Tuesday, October 1st. Bank of America upped their price objective on Integer from $135.00 to $145.00 and gave the company a "buy" rating in a research report on Tuesday, October 1st. KeyCorp upped their price objective on Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a research report on Tuesday, October 15th. Truist Financial upped their price objective on Integer from $145.00 to $150.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Finally, Benchmark increased their price target on Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Monday. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, Integer currently has an average rating of "Moderate Buy" and an average price target of $140.14.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.